{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:36:48Z","timestamp":1786117008213,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.abb.2026.110914","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:50:33Z","timestamp":1782345033000},"page":"110914","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Differential regulation of neuroinflammation and tau pathology by apolipoprotein E3 and E4 via the mTORC1 pathway: Implications for Alzheimer's disease risk"],"prefix":"10.1016","volume":"784","author":[{"given":"Yanjie","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiwen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.abb.2026.110914_bib1","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/jamaneurol.2024.0784","article-title":"Clinicopathologic heterogeneity and glial activation patterns in alzheimer disease","volume":"81","author":"Kouri","year":"2024","journal-title":"JAMA Neurol."},{"issue":"10","key":"10.1016\/j.abb.2026.110914_bib2","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The amyloid-beta pathway in Alzheimer's disease","volume":"26","author":"Hampel","year":"2021","journal-title":"Mol. Psychiatr."},{"issue":"11","key":"10.1016\/j.abb.2026.110914_bib3","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/s41590-023-01627-6","article-title":"APOE4 impairs the microglial response in Alzheimer's disease by inducing TGFbeta-mediated checkpoints","volume":"24","author":"Yin","year":"2023","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.abb.2026.110914_bib4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JAD-180740","article-title":"The role of apolipoprotein E isoforms in Alzheimer's disease","volume":"68","author":"Roda","year":"2019","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.abb.2026.110914_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/(SICI)1097-4547(19970701)49:1<9::AID-JNR2>3.0.CO;2-H","article-title":"Association of human, rat, and rabbit apolipoprotein E with beta-amyloid","volume":"49","author":"LaDu","year":"1997","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.abb.2026.110914_bib6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0896-6273(95)90079-9","article-title":"Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain","volume":"15","author":"Naslund","year":"1995","journal-title":"Neuron"},{"issue":"38","key":"10.1016\/j.abb.2026.110914_bib7","doi-asserted-by":"crossref","first-page":"23403","DOI":"10.1016\/S0021-9258(17)31529-6","article-title":"Isoform-specific binding of apolipoprotein E to beta-amyloid","volume":"269","author":"LaDu","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.abb.2026.110914_bib8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer's disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.abb.2026.110914_bib9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1006\/exnr.1999.7199","article-title":"Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor","volume":"160","author":"Veerhuis","year":"1999","journal-title":"Exp. Neurol."},{"issue":"10","key":"10.1016\/j.abb.2026.110914_bib10","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/00005072-199655100-00008","article-title":"Inflammation, A beta deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration","volume":"55","author":"Lue","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"Pt 20","key":"10.1016\/j.abb.2026.110914_bib11","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1242\/jcs.051011","article-title":"mTOR signaling at a glance","volume":"122","author":"Laplante","year":"2009","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.abb.2026.110914_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1750-1326-4-14","article-title":"The PI3K-Akt-mTOR pathway regulates Abeta oligomer induced neuronal cell cycle events","volume":"4","author":"Bhaskar","year":"2009","journal-title":"Mol. Neurodegener."},{"issue":"3","key":"10.1016\/j.abb.2026.110914_bib13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","article-title":"TOR signaling in growth and metabolism","volume":"124","author":"Wullschleger","year":"2006","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.abb.2026.110914_bib14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1097-2765(02)00636-6","article-title":"Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control","volume":"10","author":"Loewith","year":"2002","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.abb.2026.110914_bib15","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/bmb.21552","article-title":"Real-time quantitative PCR: a tool for absolute and relative quantification","volume":"49","author":"Harshitha","year":"2021","journal-title":"Biochem. Mol. Biol. Educ."},{"key":"10.1016\/j.abb.2026.110914_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.647990","article-title":"Cholesterol, atherosclerosis, and APOE in vascular contributions to cognitive impairment and dementia (VCID): potential mechanisms and therapy","volume":"13","author":"Duong","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"11","key":"10.1016\/j.abb.2026.110914_bib17","doi-asserted-by":"crossref","first-page":"767","DOI":"10.14348\/molcells.2014.0248","article-title":"Apolipoprotein E in synaptic plasticity and Alzheimer's disease: potential cellular and molecular mechanisms","volume":"37","author":"Kim","year":"2014","journal-title":"Mol. Cells"},{"issue":"2","key":"10.1016\/j.abb.2026.110914_bib18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.abb.2026.110914_bib19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00401-011-0892-1","article-title":"Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex","volume":"123","author":"Arold","year":"2012","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1016\/j.abb.2026.110914_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099939","article-title":"Mechanisms of U87 astrocytoma cell uptake and trafficking of monomeric versus protofibril Alzheimer's disease amyloid-\u03b2 proteins","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.abb.2026.110914_bib24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-1-60761-744-0_10","article-title":"Apolipoprotein E expression and purification","volume":"670","author":"Newhouse","year":"2011","journal-title":"Methods Mol. Biol."},{"issue":"89","key":"10.1016\/j.abb.2026.110914_bib25","doi-asserted-by":"crossref","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","article-title":"Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance","volume":"3","author":"Castellano","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"16","key":"10.1016\/j.abb.2026.110914_bib26","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1073\/pnas.0900345106","article-title":"Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease","volume":"106","author":"Reiman","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"21","key":"10.1016\/j.abb.2026.110914_bib27","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1523\/JNEUROSCI.0887-09.2009","article-title":"Human APOE isoform-dependent effects on brain beta-amyloid levels in PDAPP transgenic mice","volume":"29","author":"Bales","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.abb.2026.110914_bib21","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.actbio.2020.08.029","article-title":"Cell-based high-throughput screening of cationic polymers for efficient DNA and siRNA delivery","volume":"115","author":"Wu","year":"2020","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.abb.2026.110914_bib22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s13104-019-4249-5","article-title":"Estimating transfection efficiency in differentiated and undifferentiated neural cells","volume":"12","author":"Alabdullah","year":"2019","journal-title":"BMC Res. Notes"},{"issue":"1","key":"10.1016\/j.abb.2026.110914_bib23","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1038\/s41467-021-24232-3","article-title":"Conservation and divergence of vulnerability and responses to stressors between human and mouse astrocytes","volume":"12","author":"Li","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.abb.2026.110914_bib28","first-page":"43","article-title":"Alzheimer's disease puzzle: delving into pathogenesis hypotheses","volume":"15","author":"Nasb","year":"2024","journal-title":"Aging Dis"},{"key":"10.1016\/j.abb.2026.110914_bib29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.semcdb.2021.07.009","article-title":"eIF2-dependent translation initiation: memory consolidation and disruption in Alzheimer's disease","volume":"125","author":"Oliveira","year":"2022","journal-title":"Semin. Cell Dev. Biol."},{"issue":"9","key":"10.1016\/j.abb.2026.110914_bib30","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1093\/brain\/awaa223","article-title":"Phosphorylated tau interactome in the human Alzheimer's disease brain","volume":"143","author":"Drummond","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.abb.2026.110914_bib31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neulet.2019.04.022","article-title":"The complexity of tau in Alzheimer's disease","volume":"705","author":"Naseri","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.abb.2026.110914_bib32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fnmol.2014.00022","article-title":"Roles of eIF2alpha kinases in the pathogenesis of Alzheimer's disease","volume":"7","author":"Ohno","year":"2014","journal-title":"Front. Mol. Neurosci."},{"issue":"7","key":"10.1016\/j.abb.2026.110914_bib33","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/jcp.22527","article-title":"Phosphorylation of AKT\/PKB by CK2 is necessary for the AKT-dependent up-regulation of beta-catenin transcriptional activity","volume":"226","author":"Ponce","year":"2011","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.abb.2026.110914_bib34","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0002-9440(10)63687-5","article-title":"Up-regulation of phosphorylated\/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease","volume":"163","author":"An","year":"2003","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.abb.2026.110914_bib35","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/neup.12275","article-title":"S6 kinase phosphorylated at T229 is involved in tau and actin pathologies in Alzheimer's disease","volume":"36","author":"Sonoda","year":"2016","journal-title":"Neuropathology"}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986126001852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986126001852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T13:02:45Z","timestamp":1786021365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986126001852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":35,"alternative-id":["S0003986126001852"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2026.110914","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential regulation of neuroinflammation and tau pathology by apolipoprotein E3 and E4 via the mTORC1 pathway: Implications for Alzheimer's disease risk","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2026.110914","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110914"}}